The omicron variant escapes the immune response better than other SARS-CoV-2 variants and their related coronaviruses in humans, bats and pangolins. This finding, published by a research team led by Duke-NUS Medical School ...
Oct 10, 2022
0
55
A new study published in The Lancet shows that medical abortion can be carried out both safely and effectively via telemedicine, without a routine ultrasound examination. The study, which is a collaboration between researchers ...
Sep 7, 2022
0
56
In a recent study, researchers from Karolinska Institutet and others have characterized the new omicron variant BA.2.75, comparing its ability to evade antibodies against current and previous variants. The study, published ...
Sep 2, 2022
0
56
Two pioneering studies published simultaneously today in Nature and Genome Medicine, have identified genetic signatures explaining ethnic differences in the severity of prostate cancer, particularly in sub-Saharan Africa.
Aug 31, 2022
0
75
A new study, led by researchers at the University of Oxford, UK, in collaboration with the University of California, Berkeley, U.S., published today in Lancet Diabetes & Endocrinology identifies, as early as the fifth month ...
Aug 25, 2022
0
83
No other infectious disease has killed more people than tuberculosis. Currently, only one vaccine is available to prevent severe courses: Bacillus Calmette Guérin (BCG). However, it is not equally effective against all types ...
Aug 2, 2022
0
2680
The omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. In many countries, these viruses are now outcompeted by emerging subvariants, with BA.5 being responsible for the current ...
Jul 1, 2022
0
149
Cancer cases and deaths are expected to double in Africa during the next two decades, according to findings from a new study by Penn State College of Medicine researchers. The study also reveals that the region lacks sufficient ...
Jun 14, 2022
0
46
Vaccines based on inactivated SARS-CoV-2 virus are commonly used in developing countries due to their low cost. New research from Karolinska Institutet in Sweden shows that a booster shot of mRNA vaccine to individuals who ...
May 13, 2022
0
61
The SARS-CoV-2 omicron variant's "milder" outcomes are likely due to more population immunity rather than the virus' properties, according to a paper by William Hanage, associate professor of epidemiology at Harvard T.H. ...
Feb 3, 2022
7
268
